Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad’s SPAC For NASDAQ Debut
Senti Biosciences Inc, the synthetic biology play helmed by MIT whiz Tim Lu, will be merging with Farokhzad's Dynamics Special Purpose Corp (NASDAQ: DYNS) in a